are pressing goals in clinical microbiology.
Recent technologies, such as the enzyme-linked immunosorbent
assay (ELISA), the polymerase chain reaction (PCR) and the
matrix-assisted laser desorption/ionisation time of flight mass
spectrometry (MALDI-TOF MS) have boosted the identification
and characterisation of clinically significant bacteria [1–3].
However, the research community is manifesting a renewed interest
in traditional culture-based strategies like colony morphology
characterisation as more immediate, first-term means of decision
support